| Literature DB >> 29713387 |
Basma Damiri1, Mohammed S Abualsoud2, Amjad M Samara2, Sakhaa K Salameh2.
Abstract
BACKGROUND: Metabolic syndrome (MetS) is one of the main reasons for elevated cardiovascular morbidity and mortality worldwide. Obese and overweight individuals are at high risk of developing these chronic diseases. The aim of this study was to characterize and establish sex-adjusted prevalence of metabolic syndrome and its components.Entities:
Keywords: Adults; Metabolic syndrome; Obesity and overweight
Year: 2018 PMID: 29713387 PMCID: PMC5907715 DOI: 10.1186/s13098-018-0337-2
Source DB: PubMed Journal: Diabetol Metab Syndr ISSN: 1758-5996 Impact factor: 3.320
Sex-specific body mass index in all participants (Stage 1)
| Men no. (%) | Women no. (%) | Total no. (%) | |
|---|---|---|---|
| Underweight (BMI ≤ 18.5) | 12 (3.6) | 7 (1.9) | 19 (2.8) |
| Normal weight (BMI = 18.6–24.9) | 126 (38.3) | 109 (30.3) | 235 (34.1) |
| Overweight (BMI = 25.0–29.9) | 95 (28.9) | 93 (25.8) | 188 (27.3) |
| Obesity type 1 (BMI = 30.0–34.9) | 70 (21.3) | 79 (21.9) | 148 (21.5) |
| Obesity type 2 (BMI ≥ 35.0) | 26 (7.9) | 72 (20.0) | 98 (14.2) |
| Obese and overweight (BMI ≥ 25) | 191 (58.1) | 244 (67.8) | 435 (63.1) |
| Obese and overweight agreed to participate in stage 2 | 156 | 207 | 363 |
Sex-specific prevalence of metabolic syndrome in obese and overweight based on NCEP/ATPIII vs. IDF definitions
| Gender (n) | NCEP/ATPIII | IDF | ||
|---|---|---|---|---|
| With MetS no. (%) | Without Mets no. (%) | With MetS no. (%) | Without MetS no. (%) | |
| Men (156) | 81 (51.9) | 75 (48.1) | 112 (71.8) | 44 (28.2) |
| Women (207) | 108 (52.2) | 99 (47.8) | 140 (67.6) | 67 (32.4) |
| Total (363) | 189 (52.1) | 174 (47.9) | 252 (69.4) | 111 (30.6) |
Prevalence of MetS based on different types of obesity according to both IDF and NCEP definitions
| Type of obesity | IDF n (%) | NCEP n (%) | ||||||
|---|---|---|---|---|---|---|---|---|
| With MetS | Without | Total | p value | With MetS | Without MetS | Total | p value | |
| Overweight | 95 (37.7) | 48 (43.3) | 143 (39.4) | 0.586 | 36 (25.2) | 107 (74.8) | 143 (39.4) | < 0.0001 |
| Obesity type 1 | 93 (36.9) | 36 (32.4) | 129 (35.5) | 80 (62.0) | 49 (38.0) | 129 (35.5) | ||
| Obesity type 2 | 64 (25.4) | 27 (24.3) | 91 (25.1) | 73 (80.2) | 18 (19.8) | 91 (25.1) | ||
| Total | 252 (69.4) | 111 (30.6) | 363 (100) | < 0.0001 | 189 (52.1) | 174 (47.9) | 363 (100) | 0.431 |
Clustering of metabolic syndrome components in obese and overweight according to IDF definition
| Men no. (%) | Women no. (%) | Total no. (%) | |
|---|---|---|---|
| Without MetS | |||
| Normal WC | 45 (28.8) | 23 (11.1) | 68 (18.7) |
| High WC only | 6 (3.8) | 8 (3.9) | 14 (3.9) |
| High WC with 1 component | 28 (17.9) | 49 (23.7) | 77 (21.2) |
| With MetS | |||
| High WC with 2 components | 33 (21.2) | 54 (26.1) | 87 (24.0) |
| High WC with 3 components | 32 (20.5) | 57 (27.5) | 89 (24.5) |
| High WC with 4 components | 12 (7.7) | 16 (7.7) | 28 (7.7) |
WC waist circumference
Fig. 1Clustering of the metabolic syndrome components in obese and overweight participants according to NCEP/ATP III criteria. The majority of (52.1%) have three or more components and only 4.7% lack all components of MetS. Sex-specific metabolic abnormalities in obese and overweight when the NCEP/ATP III criterion is applied had shown also variations in clustering MetS components
Sex-specific prevalence of metabolic abnormalities among obese and overweight participants according to NCEP/ATP III and IDF criteria
| All no. (%) | Men no. (%) | Women no. (%) | p value | |
|---|---|---|---|---|
| WC (NCEP) | 205 (56.5) | 68 (43.6) | 137 (66.2) | < 0.0002 |
| WC (IDF) | 295 (81.3) | 111 (71.1) | 184 (88.9) | < 0.0002 |
| FBS (NCEP) | 203 (56.0) | 82 (52.6) | 121 (58.8) | 0.26 |
| FBS (IDF) | 237 (65.3) | 92 (59) | 145 (70) | 0.028 |
| BP | 174 (48.0) | 80 (51.3) | 94 (45.4) | 0.27 |
| HDL | 239 (65.8) | 100 (64.1) | 139 (67.1) | 0.54 |
| TG | 115 (31.7) | 56 (35.9) | 59 (28.5) | 0.13 |
WC waist circumference, BP blood pressure, HDL high density lipoprotein, TG triglycerides, FBS fasting blood sugar
Prevalence of metabolic syndrome according to socioeconomic and demographic factors using NCEP/ATPIII and IDF criteria
| NCEP/ATPIII | With MetS (n = 189) | Without MetS (n = 174) | p value* |
|---|---|---|---|
| Residency | |||
| Balata | 88 | 89 | 0.297 |
| Asker | 72 | 53 | |
| Al Ein | 29 | 32 | |
| Income | |||
| Low | 92 | 81 | 0.257 |
| Intermediate | 82 | 70 | |
| High | 15 | 23 | |
| Marital status | |||
| Married | 167 | 148 | 0.353 |
| Unmarried | 22 | 26 | |
* p value < 0.05 considered statistically significant. Chi square test was used
Prevalence of MetS among obese and overweight based on modified NCEP/ATP III criteria, according to lifestyle
| With MetS (n = 189) | Without MetS (n = 174) | Odds ratio (CI) | p value* | |
|---|---|---|---|---|
| Smoking | ||||
| Yes | 55 | 60 | 0.78 (0.50–1.21) | 0.271 |
| No | 134 | 114 | ||
| Walking ≥ 1 h/day | ||||
| Yes | 76 | 97 | 0.53 (0.35–0.81) | 0.003 |
| No | 113 | 77 | ||
| Additional sports | ||||
| Yes | 15 | 19 | 0.70 (0.35–1.43) | 0.330 |
| No | 174 | 155 | ||
| ≥ 4 h/day of TV or computer | ||||
| Yes | 63 | 61 | 0.93 (0.60–1.43) | 0.729 |
| No | 126 | 113 | ||
| Family history of HTN/DM | ||||
| Yes | 155 | 138 | 1.19 (0.71–2.0) | 0.59 |
| No | 34 | 36 | ||
* p value < 0.05 considered statistically significant. Chi square test was used
Prevalence of MetS among obese and overweight based on IDF criteria, according to lifestyle
| With MetS (n = 252) | Without MetS (n = 111) | Odds ratio (CI) | p value* | |
|---|---|---|---|---|
| Smoking | ||||
| Yes | 84 | 31 | 1.29 (0.79–2.1) | 0.308 |
| No | 168 | 80 | ||
| Walking ≥ 1 h/day | ||||
| Yes | 123 | 50 | 1.16 (0.74–1.82) | 0.508 |
| No | 129 | 61 | ||
| Additional sports | ||||
| Yes | 25 | 9 | 1.25 (0.56–2.77) | 0.585 |
| No | 227 | 102 | ||
| ≥ 4 h/day of TV or computer | ||||
| Yes | 86 | 38 | 1.00 (0.62–1.60) | 0.984 |
| No | 166 | 73 | ||
| Family history of HTN/DM | ||||
| Yes | 208 | 85 | 1.45 (0.84–2.50) | 0.185 |
| No | 44 | 26 | ||
* p value < 0.05 considered statistically significant. Chi square test was used
HTN hypertension, DM diabetes mellitus